205 related articles for article (PubMed ID: 23271353)
41. The microenvironment in lymphomas--dissecting the complex crosstalk between tumor cells and 'by-stander' cells.
Rosenquist R; Davi F; Ghia P
Semin Cancer Biol; 2014 Feb; 24():1-2. PubMed ID: 24365642
[TBL] [Abstract][Full Text] [Related]
42. Integrated single cell analysis reveals co-evolution of malignant B cells and tumor micro-environment in transformed follicular lymphoma.
Sarkozy C; Wu S; Takata K; Aoki T; Neriah SB; Milne K; Goodyear T; Strong C; Rastogi T; Hilton LK; Lai D; Sehn LH; Farinha P; Nelson BH; Weng A; Marra M; Scott DW; Craig JW; Steidl C; Roth A
Cancer Cell; 2024 Jun; 42(6):1003-1017.e6. PubMed ID: 38861923
[TBL] [Abstract][Full Text] [Related]
43. New agents in follicular lymphoma.
Cheson BD
Best Pract Res Clin Haematol; 2011 Jun; 24(2):305-12. PubMed ID: 21658626
[TBL] [Abstract][Full Text] [Related]
44. CD5-positive diffuse large B cell lymphoma arising from a CD5-positive follicular lymphoma.
Vassallo J; Bousquet M; Quelen C; Al Saati T; Delsol G; Brousset P
J Clin Pathol; 2007 May; 60(5):573-5. PubMed ID: 17513519
[TBL] [Abstract][Full Text] [Related]
45. Pathology, pathogenesis and molecular genetics of follicular NHL.
Leich E; Ott G; Rosenwald A
Best Pract Res Clin Haematol; 2011 Jun; 24(2):95-109. PubMed ID: 21658611
[TBL] [Abstract][Full Text] [Related]
46. Functional alteration of the lymphoma stromal cell niche by the cytokine context: role of indoleamine-2,3 dioxygenase.
Maby-El Hajjami H; Amé-Thomas P; Pangault C; Tribut O; DeVos J; Jean R; Bescher N; Monvoisin C; Dulong J; Lamy T; Fest T; Tarte K
Cancer Res; 2009 Apr; 69(7):3228-37. PubMed ID: 19276371
[TBL] [Abstract][Full Text] [Related]
47. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
[TBL] [Abstract][Full Text] [Related]
48. Cell growth in aggregates determines gene expression, proliferation, survival, chemoresistance, and sensitivity to immune effectors in follicular lymphoma.
Gravelle P; Jean C; Familiades J; Decaup E; Blanc A; Bezombes-Cagnac C; Laurent C; Savina A; Fournié JJ; Laurent G
Am J Pathol; 2014 Jan; 184(1):282-95. PubMed ID: 24231431
[TBL] [Abstract][Full Text] [Related]
49. [Significance of C4d deposition in the follicular lymphoma].
Zheng ZY; Bu XM; Wang C; Xiong XS; Wu ZZ; Yu YH
Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):227-9. PubMed ID: 17877197
[TBL] [Abstract][Full Text] [Related]
50. Cell migration patterns and ongoing somatic mutations in the progression of follicular lymphoma.
Adam P; Schoof J; Hartmann M; Schwarz S; Puppe B; Ott M; Rosenwald A; Ott G; Muller-Hermelink HK
Cytogenet Genome Res; 2007; 118(2-4):328-36. PubMed ID: 18000387
[TBL] [Abstract][Full Text] [Related]
51. Cell cross talk within the lymphoma tumor microenvironment: follicular lymphoma as a paradigm.
Laurent C; Dietrich S; Tarte K
Blood; 2024 Mar; 143(12):1080-1090. PubMed ID: 38096368
[TBL] [Abstract][Full Text] [Related]
52. Advances in the multi-omics landscape of follicular lymphoma.
Xu T; Zheng Z; Zhao W
Int J Biol Sci; 2023; 19(6):1955-1967. PubMed ID: 37063433
[TBL] [Abstract][Full Text] [Related]
53. TGFbeta-mediated activation of Smad1 in B-cell non-Hodgkin's lymphoma and effect on cell proliferation.
Munoz O; Fend F; de Beaumont R; Husson H; Astier A; Freedman AS
Leukemia; 2004 Dec; 18(12):2015-25. PubMed ID: 15470494
[TBL] [Abstract][Full Text] [Related]
54. Follicular lymphoma microenvironment: insights provided by single-cell analysis.
Abe Y
J Clin Exp Hematop; 2023 Sep; 63(3):143-151. PubMed ID: 37635086
[TBL] [Abstract][Full Text] [Related]
55. In situ follicular lymphoma associated with overt B- or T-cell lymphomas in the same lymph node.
Carbone A; Della Libera D; Zannier L; Selva A; Ceolin P; Gualeni A; Canal B; Gloghini A
Am J Hematol; 2011 Dec; 86(12):E66-70. PubMed ID: 21956856
[TBL] [Abstract][Full Text] [Related]
56. gammadelta T lymphocytes count is normal and expandable in peripheral blood of patients with follicular lymphoma, whereas it is decreased in tumor lymph nodes compared with inflammatory lymph nodes.
Braza MS; Caraux A; Rousset T; Lafaye de Micheaux S; Sicard H; Squiban P; Costes V; Klein B; Rossi JF
J Immunol; 2010 Jan; 184(1):134-40. PubMed ID: 19949101
[TBL] [Abstract][Full Text] [Related]
57. Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry.
Liu L; Yu X; Li Z; He X; Zha J; Lin Z; Hong Y; Zheng H; Lai Q; Ding K; Jia X; Fu G; Yu H; Yang H; Li Z; Young KH; Xu B
J Hematol Oncol; 2022 Aug; 15(1):115. PubMed ID: 35996180
[TBL] [Abstract][Full Text] [Related]
58. Prognosis of follicular lymphomas.
Luminari S; Federico M
Hematol Oncol; 2006 Jun; 24(2):64-72. PubMed ID: 16514592
[TBL] [Abstract][Full Text] [Related]
59. Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy.
Ramsay AG; Clear AJ; Kelly G; Fatah R; Matthews J; Macdougall F; Lister TA; Lee AM; Calaminici M; Gribben JG
Blood; 2009 Nov; 114(21):4713-20. PubMed ID: 19786615
[TBL] [Abstract][Full Text] [Related]
60. Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles.
Hellmuth JC; Louissaint A; Szczepanowski M; Haebe S; Pastore A; Alig S; Staiger AM; Hartmann S; Kridel R; Ducar MD; Koch P; Dreyling M; Hansmann ML; Ott G; Rosenwald A; Gascoyne RD; Weinstock DM; Hiddemann W; Klapper W; Weigert O
Blood; 2018 Oct; 132(16):1695-1702. PubMed ID: 30126979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
